Medicare to publish drugs selected for third round of price negotiations by Feb. 1

The Centers for Medicare & Medicaid Services (CMS) has sought public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing negotiations by Feb. 1, 2026.

Issuing a draft guidance on